Literature DB >> 11406763

Efficient retrovirus-mediated transduction of primitive human peripheral blood progenitor cells in stroma-free suspension culture.

F Berger1, D Soligo, K Schwarz, P Bossolasco, H Schrezenmeier, B Kubanek, G L Deliliers, T Licht.   

Abstract

Retroviral transduction of hematopoietic cells has resulted in unsatisfactory gene marking in clinical studies. Since cytokine-stimulated stem cells have engrafted poorly in animal models, we investigated phenotypic changes during culture of peripheral blood progenitor cells (PBPC). Human CD34(+) HLA-DR(low) cells, immunomagnetically separated from PBPC collections, were found to extrude rhodamine-123, which is characteristic for primitive hematopoietic cells. Cells were grown in suspension cultures supplemented with cytokines. While interleukin-3-containing factor combinations promoted cell proliferation they caused loss of rhodamine-123 extrusion and reduced the frequencies of cobblestone area-forming cells (CAFC). Several other cytokines failed to stimulate cell divisions, which are required for retroviral transduction. A combination including Flt-3 ligand (FL), interleukin-6 and stem cell factor (SCF) preserved an immature phenotype for 5 to 6 days and stimulated cell divisions, which was improved upon addition of leukemia inhibitory factor and interleukin-11. Furthermore, the CAFC frequency among cells treated with these cytokines was increased as compared with widely used cocktails containing interleukin-3, interleukin-6 and SCF. Rhodamine-123 appeared to be a particularly sensitive indicator for differentiation of PBPC. For analysis of gene transfer, amphotropic retroviruses conferring an MDR1 cDNA were added repeatedly for 6 days to cytokine-treated PBPC stroma-free cultures. Proviral cDNA was detected by polymerase chain reaction in 68% of cobblestone areas derived from CD34(+)HLA-DR(low) cells that had been exposed to Flt-3 ligand, interleukin-6 and SCF. In summary, conditions were identified that facilitate efficient transduction of early PBPC with amphotropic retroviruses while preserving a primitive phenotype for extended periods.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11406763     DOI: 10.1038/sj.gt.3301455

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  2 in total

1.  Potent Antitumor Activity Generated by a Novel Tumor Specific Cytotoxic T Cell.

Authors:  Zheng Wang; Pei Li; Qinhong Xu; Jun Xu; Xuqi Li; Xufeng Zhang; Qingyong Ma; Zheng Wu
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

2.  Pancreatic carcinoma-specific immunotherapy using novel tumor specific cytotoxic T cells.

Authors:  Jianjun Lei; Zheng Wu; Zhengdong Jiang; Jiahui Li; Liang Zong; Xin Chen; Wanxing Duan; Qinhong Xu; Lun Zhang; Liang Han; Qingyong Ma; Zheng Wang; Dong Zhang
Journal:  Oncotarget       Date:  2016-12-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.